Tempest Therapeutics Inc. (TPST) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tempest Therapeutics Inc.

    NASDAQ: TPST · Real-Time Price · USD
    10.40
    -0.37 (-3.44%)
    At close: Oct 03, 2025, 3:59 PM
    10.54
    1.35%
    After-hours: Oct 03, 2025, 07:54 PM EDT

    Tempest Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -7.24 -2.3 -0.37 -0.05
    PEG Ratio
    		 0.34 0.06 0.01 0.00
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 15.83 2.53 0.73 0.04
    P/FCF Ratio
    		 -9.05 -2.46 -0.42 -0.06
    P/OCF Ratio
    		 -9.17 -2.48 -0.43 -0.06
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.80 0.77 1.22 0.51
    Quick Ratio
    		 2.21 4.29 4.53 3.44
    Current Ratio
    		 2.21 4.29 4.53 3.44
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 -31.93 -20.12 -21.41 -21.05
    Return on Equity
    		 -2.19 -1.1 -1.97 -0.78
    Return on Assets
    		 -1.01 -0.57 -0.77 -0.39
    Return on Invested Capital
    		 -1.22 -0.61 -0.86 -0.49
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist